Covid-19 News and Discussions


Mo. Independent: COVID surges across Kansas and Missouri as free shots go away​


By Suzanne King Missouri
PUBLISHED 2:23 PM CT Aug. 15, 2024

Last year, when COVID vaccines were still free, barely one in five Americans rolled up their sleeves for the latest dose.

Now that some people will have to pay $100-plus for the shot, health officials expect even weaker demand when the next version of the vaccine comes out this fall.

Meanwhile, a surprisingly strong summer surge of COVID cases sweeps across Kansas and Missouri.

As students head back to school, more people are testing positive, ending up in emergency rooms and getting hospitalized with the virus, according to the U.S. Centers for Disease Control and Prevention.

In Kansas City, the reported case rate at the end of July was more than double the same week last year and edging toward last winter’s rate. At the same time, wastewater testing in Kansas and Missouri showed viral activity that surpassed national and regional levels.

Of course, the virus is nothing like it used to be. At the height of the pandemic in January of 2021, the CDC reported that almost 30% of weekly deaths in the U.S. could be attributed to COVID. For the week of Aug. 3, the disease was blamed for 1.5% of U.S. deaths.

But the picture would look quite different without the vaccine, experts said. At the same time, some health professionals trace August’s surge to low vaccination rates last September and October.

“The urgency of COVID has obviously gone down,” said Cecelia Thomas, a health policy consultant with Washington-based Venn Strategies. “People are now getting it or they’re seeing people get it and it’s like a cold. Not even a bad cold. But I don’t think they’re realizing that it’s not as bad because they are vaccinated.”

Immunity wanes over time as the virus mutates. Getting an updated COVID shot every year, doctors advise, helps your immune system keep pace with changes. But last year, as life seemed to have returned to normal for most people, many Americans took a pass on the COVID shot.

At the start of December, the height of vaccine season, only 16% of adults had gotten the updated shot. The rate had only ticked up to 22.5% by the middle of May.

Surprise summer surge​

Scientists have come to expect a summer rise in COVID cases because the virus is cyclical, ebbing and waning in temperate climates as seasons change. But the current COVID surge has caught some health experts by surprise. It’s infecting more people and sending more patients to hospitals.

Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, blames the higher than expected number of cases on last year’s lackluster vaccination rates.

“Many of the people being hospitalized today did not receive the vaccine last fall,” he said.

Hospitals no longer report the number of patients admitted with COVID. But at least anecdotally, doctors say, they’re seeing more people getting sick with the virus. And some people most at risk are getting really sick.

Dr. Dana Hawkinson, an infectious-disease doctor at the University of Kansas Health System, said people should be aware of the current risk, especially if their age or underlying health puts them at higher risk for getting severely ill.

“Have a plan,” he said, “especially if you are at high risk.”

That can include wearing a mask in crowded places, being careful about hand hygiene, avoiding touching your eyes, nose and mouth when in public and, of course, getting up to date on your vaccine.

An updated COVID vaccine, recommended annually for anyone 6 months and older, can prevent severe illness and reduce the chances that you’ll end up with long COVID.

But getting a current vaccine is about to get a lot harder, especially for patients who are uninsured.

COVID vaccines will likely cost more this fall​

During the height of the pandemic, COVID vaccinations were free to everyone. People only needed to sign up for an appointment online and walk into a nearby pharmacy. No cash needed.

When the federal government lifted the Public Health Emergency in May of 2023, people covered by Medicare or Medicaid and most people with private insurance could still get the shot without paying a copay. People without insurance got free shots through the $1 billion federal Bridge Access Program.

That was meant to cover the gap so all COVID shots remained free through the end of 2024. In the meantime, the CDC promised to establish a new program to make sure uninsured adults could continue getting free COVID vaccines. It was to be modeled after the federal Vaccines for Children program, which pays for vaccines for minors whose families can’t afford them.

But that program hasn’t come to fruition. And, thanks to congressional budget cuts, funding for the Bridge Access Program is running out early. Meanwhile, people with private insurance may have to pay a copay to get the shot.

For someone without insurance, the shot can cost more than $100. The Johnson County Department of Health and Environment’s website lists the out-of-pocket cost for a COVID shot as $160.

Even when a shot is covered by insurance, many health departments charge an administration fee. In Johnson County and for the Wyandotte County Public Health Department, that amounts to $20 for COVID or any other vaccine.

Vaccine access will vary by health department​

Public health officials around the Kansas City area are varied in how they plan to handle the lack of federal funding for COVID shots.

The Wyandotte County Public Health Department won’t offer any free COVID vaccines for adults this fall. Jackson County Public Health has allocated American Rescue Plan funds to cover the cost of offering free vaccines to uninsured adults through the end of the year. And Platte County is weighing how to allocate expected state funding for COVID and flu vaccines.

Money won’t stretch as far if the county chooses to offer the COVID shot, which is much more costly than the flu vaccine, said Aaron Smullin, Platte County Health Department spokesman.

“We are evaluating data on COVID/flu hospitalizations and deaths to decide how to allocate our resources,” Smullin wrote in an email response. “Without current (Bridge) funding, we face the difficult choice of whether to immunize 500 people against flu or 125 against COVID.”

Public health officials fear that any added expense and complication will lead many people to forego the shot again this fall. And that could mean more infections and hospitalizations during future a COVID surge.

The current strains of COVID infecting most people this summer — known as FLiRT variants — are related to Omicron, the version of the virus that swept across the world in late 2021. The variants are highly contagious and spread readily.

They are also still mild for most people who test positive. That’s because most people have immunity, either from previous infections or from getting the vaccine. But the evolving virus could still become more dangerous again, scientists said, which is why vaccines are so important.

“These vaccines have saved millions of lives around the world, including in the United States,” Schaffner said. “But you can’t get protected if the vaccine is in the refrigerator. It’s got to be in your arm to work.”

In addition to getting vaccinated, public health officials warn that people should test if they have symptoms and isolate and take other precautions like wearing a mask to avoid spreading the virus if they get sick. When someone tests positive, a doctor can prescribe an antiviral medication to prevent severe disease.

No-cost testing is still available at some pharmacies for people without insurance who have been exposed to COVID or have symptoms. And people who are infected, can apply for free access to antiviral medication treatments like Paxlovid.
 

Summer COVID-19 surge: What are our hospitals are seeing?​


 
 

When should you get another COVID vaccine?​


 
@Sharma Ji

The BANNED Professor's BRUTALLY Honest Opinion On COVID-19 & Dr Fauci... | Dr Bret Weinstein​


 

German Study Links Covid Shots to Surge in VITAL ORGAN DAMAGE among Children​

A team of leading scientific researchers in Germany has just issued a warning to the public after finding direct links between Covid mRNA shots and vital organ damage among children.​


LIONESS OF JUDAH MINISTRY
AUG 15, 2024
60
9
Share

Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber.

Subscribe


One-time or recurring donations can be made through Ko-Fi:





By Frank Bergman August 15, 2024

A team of leading scientific researchers in Germany has just issued a warning to the public after finding direct links between Covid mRNA shots and vital organ damage among children.

Specifically, the researchers found that Pfizer’s mRNA injection is responsible for skyrocketing cases of Immunoglobulin G4-related disease (IgG4-RD) in children aged 5 to 11 years old.

IgG4-RD is a condition that causes inflammation inside the body and damages internal organs, according to Oxford University.

It can affect many different organs, meaning people can have wide-ranging symptoms.

The pancreas is most commonly affected, followed by the bile ducts in the liver, the salivary glands, and the kidneys.

It is difficult to diagnose as there is no single test so it can often go unrecorded.

Led by physician-investigator Dr. Robin Kobbe of the University Medical Center Hamburg, the study sought to identify the cause of a surge in IgG4-RD in children.

The study, published in the Pediatric Infectious Disease Journal, found that Pfizer’s Covid mRNA shot caused the risk of IgG4-RD to spike one year after the second dose of the injection.

Kobbe and his team warn that the timespan between the injection and diagnoses may have previously made it difficult for doctors to link the shot to cases of IgG4-RD.

The German team is now raising the alarm about the importance of better understanding mRNA vaccine–specific IgG4 responses in all age groups.

They note that the anticipated growth in mRNA vaccines heading toward licensure is of grave concern.

While this German study finds a spike in organ damage in children 1 year after being injected with a Covid shot, comparable findings have been reported in adults.

The researchers warn that further investigations must be conducted to analyze the risks on a population level.

“IgG4 responses should gain more attention in health and disease, especially in the context of mRNA vaccination,” they assert.

“Understanding the unusual mechanism triggering IgG4 production is crucial, as more mRNA vaccines are currently under development and could hit the global market soon.”

This study comes amid mounting concerns about the risks to children, and adults, from the injections.

A growing number of experts and studies continue to provide evidence indicating a major health crisis among those who have received the shots.

As Slay News reported last week, a bombshell new study from top scientists at the prestigious Oxford University has raised fresh concerns about the dangers of injecting children with Covid mRNA shots.

The study uses official UK government data provided by the National Health Service (NHS) England.

NHS England granted the researchers access to the OpenSAFELY-TPP database to study the effect of the Pfizer-BioNTech Covid mRNA shot on over one million children aged 5-15.

The results of the new Oxford University study were published in the MedRxiv journal.

The study found that there were zero deaths from COVID-19 in any of the groups studied.

No unvaccinated or vaccinated kids died of COVID-19.

The researchers note that this proves the Covid shots did not save any lives among the children analyzed.

Additionally, the study found that the shots made no difference to COVID-19 infection rates among children.

However, the study did find that large numbers of children suffered from heart damage after receiving the injection.

Meanwhile, leading pharmaceutical scientists in Japan have just exposed a staggering surge in the risk of heart failure for people of all ages who have been injected with a Covid mRNA shot, as Slay News reported.

According to a team of Japanese researchers from the Division of Pharmacodynamics at Keio University Faculty of Pharmacy and Yokohama General Hospital, the risk of heart failure surges by up to 4,900% after a person receives a Covid mRNA injection.

Source: slaynews.com
 

COVID-19 boosters for children are expired, so this London mom took her kid to the U.S.​

COVID vaccine doses and boosters will be available in fall, but the exact date is unclear, says MLHU​

alessio-donnini.jpg

Alessio Donnini · CBC News · Posted: Aug 16, 2024 5:00 AM EDT | Last Updated: 2 hours ago
Kate Smith says she had to drive five hours and spend over $270 for her child to get a COVID vaccine booster she believes should be available in Ontario.

Kate Smith said she had to drive five hours and spend over $260 for her child to get a COVID-19 vaccine booster she believes should be available in Ontario. (Kate Smith)

Social Sharing​

  • Facebook
  • X
  • Email
  • Reddit
  • LinkedIn
Karen Smith said she never anticipated being unable to find a COVID-19 vaccine booster when she needed it, especially given their abundance during the height of the pandemic.

Now, more than a year after the World Health Organization declared the end of the pandemic as a global emergency, the 44-year-old London mom whose family has a history of autoimmune issues said an expired vaccine supply forced her to travel to the U.S. and pay out-of-pocket to find a booster shot for one of her children.

"We had made vaccination appointments to go on Monday to a pharmacy in London," Smith said. "I had booked everything online, and filled out all their forms."

However, her family of five ended up leaving the pharmacy that day two doses short, and with more questions than answers, she said.

"The two younger [children, 10 and 11 years old] couldn't get a dose. They told us they didn't have the paediatric strength. I quickly found out no one does."

After a series of calls to area pharmacies to ask about the availability of COVID-19 vaccine doses for children, she was told pharmacies across the province had no access to them. Smith contacted the Middlesex-London Health Unit (MLHU), who told her suitable doses for children won't be available until the fall.

"Currently, all XBB vaccine products are expiring while we wait for updated versions of COVID-19 vaccine coming in October," a spokesperson from the MLHU told CBC News. "As these vaccines expire, doses will not be available for certain ages."

According to the health unit, vaccine doses for children between five and 11 years old expired on Aug. 10, although vaccines set to expire in September are still available for children between six months and four years old. The MLHU said it's unclear when exactly new doses will be available in October as local health authorities wait for information from Ontario's Ministry of Health.

In response to a request from CBC News, the Ministry said there is a supply of vaccines for ages 5-11 available, but did not provide information regarding where those doses are available and how many are in circulation.

A child receives a Covid-19 vaccine in Winnipeg. A slow uptake by children under 12 in many provinces has health officials concerned about the immunization rate.

Different doses of COVID-19 vaccine are given to different age groups. Adult doses are for anyone aged 12 or over. Meanwhile, separate dosages exist for children between five and 12, and children between six months and four years old. (Tyson Koschik/CBC)
The revelation that two of Smith's children wouldn't be able to find a vaccine dose in Canada led her to drive to Richmond, Michigan, to have her 11-year-old son vaccinated. She said it was an ordeal that cost her roughly $260 CAD for the shot alone, and more in gas and time.

She didn't make that decision lightly she said, pointing to her experience with long-COVID and a history of genetic autoimmune issues in her family.

"The importance comes from what I've experienced [with long COVID]. It's dramatically changed my life," she said, also noting that her son has asthma, which adds to the concern. "I don't know what it could do to my child, especially with repeated infections. I'm really not comfortable with that risk."

While her son was able to be immunized in the U.S., her 10-year-old stepdaughter who doesn't have a passport is still without her booster, Smith said.

The MLHU told CBC News that continuing COVID-19 vaccination boosters are no longer being recommended for people who have already gotten their primary vaccinations.

"COVID-19 vaccination is beginning to align with other respiratory vaccines, including influenza," according to the health unit. "We will keep the public updated on the recommendations and availability of COVID-19 and influenza vaccines as we head into the fall."

Still, Smith said she'd rather not take chances and wishes public health officials made more effort to warn the public that certain shots would be expiring, and a period of unavailability was on the way.

"If all of the stock that they had was going to expire, why didn't somebody speak up for the people who might want it?" Smith said.

"We recognize a lot of people don't feel the way we feel, but it makes you wonder. Why did we waste all of this vaccine that we paid for?"
 

Japan team develops COVID treatment using synthetic immune cells​


KYODO NEWS
KYODO NEWS - 8 hours ago - 14:23 | All, Japan





A research team in Japan has developed immune cells using embryonic stem cells of human origin to treat novel coronavirus infections.

The research team, including members from Kyoto University and Fujita Health University, plans to conduct a clinical trial in three years on patients who became immunocompromised due to chemotherapy and are suffering severe symptoms of COVID-19, it said in late July.

The team artificially created cytotoxic T cells, known as "killer T cells," that attack cells infected with a virus. The cells, developed in a way to reduce the risk of rejection by patients, have genes with "sensor" functions to detect the proteins unique to the novel coronavirus.

photo_l.jpg

File photo shows nurses taking care of a patient with severe symptoms of COVID-19 at Juntendo University Hospital in Tokyo in August 2021. (Kyodo)
When the developed cells were cultured with cells infected with the novel coronavirus, around 90 percent of the latter were dead after 12 hours, according to the team also including members from Osaka University and the National Center for Child Health and Development.

The team has filed a patent application, it said.

Before the clinical trial, the team plans to conduct tests with mice to determine the safety of the treatment, which has the potential to be utilized for other viral infections through genetic alteration, according to the team.

Hiroshi Kawamoto, a Kyoto University professor who is part of the research team, said the new treatment is likely to be effective in patients who are immunocompromised as the developed cells directly attack infected cells.

In the clinical trial, the developed cells will be administered intravenously, Kawamoto said, adding that he believes the risk of the severe side effects seen in immune-based therapies is low.
 

Pfizer, BioNTech Covid-Flu Combo Shot Misses on Trial Goal​

By Damian Garde
August 16, 2024 at 9:36AM EDT
JUKNC2BTGE5XTH5T5YH7N5PQZI.jpg

syringes filled with Nuvaxovid vaccine against Covid-19 by Novavax at the Tegel vaccination center in Berlin, Germany, on Monday, Mar. 07, 2022. Photographer: Liesa Johannssen-Koppitz/Bloomberg (Liesa Johannssen-Koppitz/Bloomberg)
(Bloomberg) -- A combination Covid-flu vaccination developed by Pfizer Inc. and BioNTech SE missed on one of its goals in a final-stage trial, a setback for the companies as they search for lucrative new uses of a technology that succeeded in the pandemic.

The vaccine failed to show it was at least as effective as a standard shot in generating an immune response against the influenza B strain, the companies said in a statement Friday. The shot performed better with influenza A and Covid. Pfizer said the two companies are looking into tweaks to the vaccine that might boost its effectiveness against influenza B, work that could put them years behind rival drugmakers.

Pfizer shares fell 0.6% at 9:34 a.m. Friday in early trading in New York, while BioNTech’s depositary receipts lost 3.2%.

What Bloomberg Intelligence Says:

The Phase 3 trial failure of Pfizer-BioNTech’s combination flu/Covid vaccine may put the partners at a disadvantage vs. Moderna, which succeeded in Phase 3 in June. We see the combination shots as an important marketing and commercialization tool for the three companies to boost penetration of the respiratory-disease vaccine, helping them rival the likes of GSK and Sanofi. A reworked combination may set Pfizer-BioNTech back by at least two years, and would need a new Phase 3 trial.


— BI analyst Sam Fazeli. Read the research here.

Pfizer’s shares have fallen 19% in the last 12 months through Thursday’s close as the company has struggled to convince Wall Street that its pipeline of new medicines can one day replace its dwindling pandemic riches. Last year’s $43 billion acquisition of the cancer-focused Seagen Inc. will take years to pay off, and Pfizer’s would-be challenger to blockbuster weight-loss products like Novo Nordisk A/S’s Wegovy is unlikely to hit the market until later this decade.

The latest vaccine results complicate Pfizer’s efforts to offset the drop in sales of its BioNTech-partnered Covid vaccine. Revenue from the shot, sold as Comirnaty, fell more than 70% last year and is expected to decline about 50% more in 2024. Combining Comirnaty with a flu vaccine was meant to create a more attractive product that might increase demand.

Pfizer’s competitors are pressing forward with combination products of their own. Moderna Inc., maker of a rival Covid vaccine, reported positive late-stage results with a Covid-flu combination in June, setting the stage for a potential commercial launch in the winter of 2025. Sanofi SA, which makes a top-selling flu vaccine, signed a deal this year to work with Covid competitor Novavax Inc. on a similar project.

Pfizer’s combination vaccine study, which enrolled more than 8,000 adults, compared the combination shot against an approved flu vaccine. The company also disclosed results from a smaller, earlier-stage trial in which a second-generation combination vaccine led to a sufficient immune response against the A and B strains of influenza.
 

Covid deaths in US lower than earlier peaks amid summer surge​

Covid not as deadly in 2023 as it was in prior years, falling from the fourth to 10th leading cause of death

Melody Schreiber
Fri 16 Aug 2024 13.00 BST
Share


Covid continues surging across the US, but deaths are lower than their peaks earlier in the pandemic due in large part to vaccinations and immunity. Yet the country is still struggling to find its footing on vaccination as the virus settles into a pattern of twice-annual surges.

Covid was not as deadly in 2023 as it was in prior years, falling from the fourth to the 10th leading cause of death, according to a study by the US Centers for Disease Control and Prevention (CDC). Deaths overall fell by 6% from 2022 to 2023.


Covid vaccines have saved millions of lives, a new study in the Lancet confirms. The vaccines reduced deaths by at least 59% between December 2020 and March 2023, amounting to more than 1.6 million lives saved in Europe alone, the researchers found.


But Covid continues to cause hospitalizations and deaths, as well as disruption from illness and long Covid. More than 5% of Americans reported they were currently experiencing long Covid symptoms this spring.

The current surge has now passed last summer’s heights and continues increasing as extreme heat forces Americans indoors and precautions have largely been abandoned.

Everyone over the age of six months should get the updated Covid booster, which is expected in coming weeks, the CDC says.

But knowledge and uptake of new boosters has flagged. Only 22.3% of adults and 14.9% of children in the US are up to date on vaccines.

Even for those who want the new boosters, finding them can be a challenge – especially in summer months, when pharmacies and physicians may be wary of ordering new shots only to discard them when the new booster rolls out in the fall.


Leigh Anne Riedman, a mother of four in Santa Barbara, California, has been searching for vaccines for her children to no avail. It has been a few months since they had Covid, and she wants them to be protected during this summer surge, especially as they head back to school next week – but she has had no luck.

“There’s not the usual clinics that were there at the beginning where you would just drive up and get the shot. For the pediatric shots, you have to make the appointment at the doctor’s office,” she said.

“And they just flatly said, ‘We don’t have any and we won’t have any until we get the ones in September. We don’t know when that’s going to be, but start calling back in September to get an appointment.’”

Next, she started searching the websites of local pharmacies, including major ones like CVS, Walgreens and Rite Aid.

Getting younger kids vaccinated can be particularly complicated; major pharmacies will not vaccinate children under a certain age, such as three years or 18 months.

Riedman’s kids are 11, 15, 16, and 18, but she still was unable to find any vaccination appointments at local pharmacies.

“They didn’t have any of it,” she said. “One of them was saying that I could drive about an hour to get the shot.”

Even vaccines.gov no longer lists open vaccine appointments. The CDC will add a pharmacy locator tool once the new boosters are available, according to a message on the site.

“It’s a flashback to the beginning days,” Riedman said, when vaccines first came out and she would constantly refresh websites hunting for an appointment.

Now, she will be sending her kids back to school at the peak of a major outbreak without the protection of recent vaccination. She hopes to snag an appointment in September. Whether the kids receive last season’s booster or this season’s shot doesn’t matter to her so much as getting it quickly.

For other people, the issue may not be availability, but knowledge of when boosters come out and how long protection lasts.

“We live in a confused maze of Covid vaccine understanding,” said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. A major part of the problem, he said, was that the US has adopted the annual vaccination strategy of a virus like the flu or RSV – but Covid has, from the beginning, fallen into a year-long transmission pattern.

“We’ve not set up our vaccines that way,” Osterholm said. “What we have to do is get away from this idea that you could [only] vaccinate for Covid in the late fall, early winter.”


Especially those at risk, including people over the age of 65 and those with medical conditions, must get vaccinated twice a year in order to prevent serious illness, hospitalization and deaths, he said.

Two of Riedman’s children have medical conditions, and one of her kids was hospitalized with Covid in the past. She desperately wants to avoid that again. Her kids will wear masks this fall, but she’s worried they are at higher risk the longer they wait for vaccines.

“It feels very much like you’re just cut loose and you’re on your own these days,” she said.

It reminds her of earlier in the pandemic, when there was a long wait for Covid vaccines to be approved for children: “It felt like people were playing fast and loose with the health of these kids.”

Osterholm, in Minnesota, was able to get another Covid booster for himself. “I know I won’t be able to get the new Flirt variant vaccine, the mRNA [shot], for four months now, but the peak is right now,” he said.

He called for greater investment in vaccine research and development, as well as manufacturing capacity, which would strengthen the Covid response and improve future responses to other emerging viruses.

Without that, Osterholm said, “we’re less prepared today than we were in 2019 for pandemic response.”
 

COVID cases on the rise locally and nationally​


 

Arkansas health official advises caution as schools reopen amid COVID spread​


 

The US is experiencing its largest summer Covid wave in at least two years​


By Brenda Goodman, CNN
4 minute read
Updated 1:18 PM EDT, Fri August 16, 2024

“Currently, the COVID-19 wastewater viral activity level is very high nationally, with the highest levels in the Western US region,” Dr. Jonathan Yoder, deputy director of the CDC’s Wastewater Surveillance Program, said in an email. “This year’s COVID-19 wave is coming earlier than last year, which occurred in late August/early September.”

Emergency room visits, hospitalizations and deaths are also ticking up, although not to the same extent as infections, according to the CDC’s Covid dashboard. As of the end of July, the CDC’s dashboard shows about 4 are being hospitalized for Covid for every 100,000 people in a given area, up from a low in May of about one Covid hospitalization for every 100,000 people – the lowest level since the pandemic began.

The CDC’s wastewater data closely aligns with what they’re seeing at the nationwide WastewaterScan network, too.

“This is a very significant surge. The levels are very high. They’re the highest we’ve ever seen during a summer wave,” said Dr. Marlene Wolfe, an assistant professor of environmental health and public health at Emory University and a program director for WastewaterScan. “We’re detecting SARS-CoV-2 in 100 percent of our samples across the country right now.”

Health officials no longer track the coronavirus as closely as they did during the public health emergency, and there are no longer reliable estimates of daily or weekly new infections in the US. Instead, the nation is largely relying on wastewater levels to follow numbers of new cases.

Wolfe says the amount of virus in wastewater doesn’t precisely correlate to numbers of infections. That’s because there are a host of things that can influence how much virus is in wastewater – including how much water is flowing through the sewage system when sampling takes place, as well as how much virus people may be shedding with a given variant. Despite these variables, she says sampling over time has shown there is a strong relationship between the number of people infected in a given area and the amount of virus in local wastewater.

“We can’t say exactly how many more cases that may be compared to previous years, because some of those changes might have happened in the virus in the areas that we’re measuring,” she said.

The rise in cases is being driven by waning immunity in the population and a trio of new variants that have drifted enough from their parent virus, JN.1, to escape the ability of our antibodies to quickly neutralize them.

Cases are also climbing just as children head back to classrooms in many parts of the US, giving the infection plenty of opportunity to spread.

It’s not clear when this surge will peak and start to taper off.

“Here in Houston, Texas, wastewater numbers are still high and not declining. They have reached a plateau at a high level for several weeks,” said Dr. Peter Hotez, an infectious disease expert who is director of the Center for Vaccine Development at Texas Children’s Hospital.

The surge of cases has also come ahead of the availability of an updated Covid-19 vaccine designed to better protect against the new variants, which could help slow the spread of the virus.

“It’s a bit disappointing that these are not available now, as Covid is surging,” Hotez said.

The US Food and Drug Administration has not yet approved the latest tweaks to the Covid-19 vaccines, but experts say they’ve heard that updated shots from Pfizer, Moderna and Novavax should be ready in the coming weeks.

In June, the FDA, following its normal process of reevaluating the need for changes to the Covid vaccines, directed manufacturers to update their shots for the fall to better match the variants that were making people sick.

“We keep hearing rumors that it will be here by the end of September, so we shouldn’t have to wait too long,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University.

The best thing people can do as far as their own personal risk is to get that vaccine when it does become available, Hotez said.

“Next, of course, is a good N95 or KN95 mask when you are in crowded indoor areas,” Hotez said, and seek out the antiviral medication Paxlovid if you test positive. For that reason, it’s also a good idea to stock up on Covid-19 tests to identify whether any coughs or runny noses are being caused by the coronavirus.

This story has been updated to include the latest wastewater surveillance data from the US Centers for Disease Control and Prevention.
 

Weekly case numbers from around Australia: 5,415 new cases (🔻4%)​

Australia: Case Update

Weekly case numbers from around Australia: 5,415 new cases (🔻4%)

  • NSW 2,486 new cases (🔺2%)
  • VIC 888 new cases (🔺12%)
  • QLD 1,518 new cases (🔻18%)
  • WA 223 new cases (🔻19%)
  • SA 145 new cases (🔺21%)
  • TAS 36 new cases (🔻23%)
  • ACT 77 new cases (🔺54%)
  • NT 42 new cases (🔻16%)
These numbers suggest a national estimate of 110K to 160K new cases this week or 0.4 to 0.6% of the population (1 in 192 people).

This gives a 50% chance that at least 1 person in a group of 133 being infected with covid this week.

r/CoronavirusDownunder - Weekly case numbers from around Australia: 5,415 new cases (🔻4%)
Flu tracker tracks cold and flu symptoms (fever plus cough) and is another useful tool for tracking the level of respiratory viruses in the community. This stayed the same at 2% for the week to Sunday and suggests 520K infections (1 in 50 people). This is on par with the seasonal average.

  • NSW: 2.1% (🔺0.6%)
  • VIC: 2% (🔺0.1%)
  • QLD: 2% (🔻1.1%)
  • WA: 1.7% (🔻0.6%)
  • SA: 1.5% (🔻0.7%)
  • TAS: 2.5% (🔺1.0%)
  • ACT: 2.3% (🔺0.8%)
  • NT: 2.3% (🔻0.3%)
Based on the testing data provided, this suggests around 158K new symptomatic covid cases this week (0.6% or 1 in 165 people).

This gives a 50% chance that at least 1 person in a group of 114 being infected with covid and 1 person in a group of 34 being sick with something (covid, flu, etc) this week.
 

Users who are viewing this thread

Back
Top